首页 > 最新文献

National Journal of Health Sciences最新文献

英文 中文
Current Trends Regarding Perioperative Pharmacological Anticoagulation in Lower Limb Surgeries among Orthopedic Surgeons of Pakistan -An Audit 巴基斯坦骨科医生下肢手术围手术期药物抗凝的现状——一项审计
Pub Date : 2022-09-30 DOI: 10.21089/njhs.73.0124
Sheikh Muhammad Ebad Ali, Badaruddin Sahito, Syeda Iqra Qadri, Hira Iqbal Naviwala, H. Khan, O. Awan, Muhammad Mohsin Mushtaq
Abstract:Perioperative anticoagulation has been recommended by AAOS, AACP, and ASH during orthopedic procedures of the lower limb. Guidelines show a difference of opinion regarding the optimum duration and drug of choice giving a way to use different methods of anticoagulation. This audit assessed the preferences for pharmacological anticoagulation in lower limb surgeries among orthopedic surgeons of Pakistan. Materials and Methods: An online questionnaire-based cross-sectional study was started from June-September 2021 in Dr Ruth K.M. Pfau Civil Hospital Karachi where Orthopedic surgeons (n=632) were invited to fill those questionnaires. A total of 85 orthopedic surgeons responded completely. An electronic eight-question survey was designed which included questions about demographics of surgeons, the drug of choice, perioperative duration, preferred surgeries, and average incidence of thromboembolism per year. Results: 12.9% surgeons use anticoagulation for all surgeries while 82.3% of orthopedic surgeons use anticoagulants in selective surgeries. LMWH (94.1%) and Rivaroxaban (17.6%) were the drug of choice for most surgeons. 70.6% of respondents never used anticoagulation preoperatively. 17.7% used it three days preoperatively. 28.24% of surgeons prescribed anticoagulation for 3 days postoperatively while 17.7% of surgeons prescribed anticoagulation for 2 weeks postoperatively. 10.6% of surgeons never used anticoagulation postoperatively. Arthroplasty (71.7%), trauma (55.3%), and pelvis and acetabulum (54.1%) were the subspecialties with routine anticoagulation. 81.2% and 17.7% of surgeons reported less than 1% and 1% to 3% incidence of thromboembolism, respectively. No surgeon reported any incidence of thromboembolism above 5%. Conclusion: Use of anticoagulation is prevalent among orthopedic surgeons in Pakistan. However, significant differences are observed regarding the perioperative duration. The surgeons need to prescribe DOAC such as Rivaroxaban and Dabigatran as agents of choice while extended postoperative pharmacological anticoagulation of 28-35 days needs to be adopted.
摘要:AAOS、AACP和ASH推荐在下肢骨科手术中进行围手术期抗凝治疗。指南显示了关于最佳持续时间和药物选择的不同意见,给出了使用不同抗凝方法的方法。本审计评估了巴基斯坦骨科医生在下肢手术中对药物抗凝的偏好。材料与方法:一项基于在线问卷的横断面研究于2021年6月至9月在Dr Ruth K.M. Pfau卡拉奇民用医院开始,邀请骨科医生(n=632)填写这些问卷。共有85名骨科医生完全回应。设计了一份包含8个问题的电子调查,其中包括外科医生的人口统计学、选择的药物、围手术期、首选手术和每年血栓栓塞的平均发病率。结果:12.9%的外科医生在所有手术中使用抗凝剂,82.3%的骨科医生在选择性手术中使用抗凝剂。低分子肝素(94.1%)和利伐沙班(17.6%)是大多数外科医生的首选药物。70.6%的受访者术前未使用抗凝剂。17.7%的患者术前3天使用。28.24%的医生术后3天使用抗凝剂,17.7%的医生术后2周使用抗凝剂。10.6%的外科医生术后未使用抗凝剂。关节成形术(71.7%)、外伤(55.3%)、骨盆和髋臼(54.1%)是常规抗凝的亚专科。81.2%和17.7%的外科医生报告血栓栓塞发生率分别低于1%和1%至3%。没有外科医生报告血栓栓塞发生率超过5%。结论:抗凝剂的使用在巴基斯坦骨科医生中很普遍。然而,围手术期观察到显著差异。外科医生需要开利伐沙班、达比加群等DOAC作为首选药物,同时需要采用术后28-35天的延长抗凝药物。
{"title":"Current Trends Regarding Perioperative Pharmacological Anticoagulation in Lower Limb Surgeries among Orthopedic Surgeons of Pakistan -An Audit","authors":"Sheikh Muhammad Ebad Ali, Badaruddin Sahito, Syeda Iqra Qadri, Hira Iqbal Naviwala, H. Khan, O. Awan, Muhammad Mohsin Mushtaq","doi":"10.21089/njhs.73.0124","DOIUrl":"https://doi.org/10.21089/njhs.73.0124","url":null,"abstract":"Abstract:Perioperative anticoagulation has been recommended by AAOS, AACP, and ASH during orthopedic procedures of the lower limb. Guidelines show a difference of opinion regarding the optimum duration and drug of choice giving a way to use different methods of anticoagulation. This audit assessed the preferences for pharmacological anticoagulation in lower limb surgeries among orthopedic surgeons of Pakistan. Materials and Methods: An online questionnaire-based cross-sectional study was started from June-September 2021 in Dr Ruth K.M. Pfau Civil Hospital Karachi where Orthopedic surgeons (n=632) were invited to fill those questionnaires. A total of 85 orthopedic surgeons responded completely. An electronic eight-question survey was designed which included questions about demographics of surgeons, the drug of choice, perioperative duration, preferred surgeries, and average incidence of thromboembolism per year. Results: 12.9% surgeons use anticoagulation for all surgeries while 82.3% of orthopedic surgeons use anticoagulants in selective surgeries. LMWH (94.1%) and Rivaroxaban (17.6%) were the drug of choice for most surgeons. 70.6% of respondents never used anticoagulation preoperatively. 17.7% used it three days preoperatively. 28.24% of surgeons prescribed anticoagulation for 3 days postoperatively while 17.7% of surgeons prescribed anticoagulation for 2 weeks postoperatively. 10.6% of surgeons never used anticoagulation postoperatively. Arthroplasty (71.7%), trauma (55.3%), and pelvis and acetabulum (54.1%) were the subspecialties with routine anticoagulation. 81.2% and 17.7% of surgeons reported less than 1% and 1% to 3% incidence of thromboembolism, respectively. No surgeon reported any incidence of thromboembolism above 5%. Conclusion: Use of anticoagulation is prevalent among orthopedic surgeons in Pakistan. However, significant differences are observed regarding the perioperative duration. The surgeons need to prescribe DOAC such as Rivaroxaban and Dabigatran as agents of choice while extended postoperative pharmacological anticoagulation of 28-35 days needs to be adopted.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127814139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency and Etiology of Pediatric Trauma, Experience at Tertiary Care Hospital 儿科创伤的频率和病因学,三级护理医院的经验
Pub Date : 2022-09-30 DOI: 10.21089/njhs.73.0121
M. Bashir, Aisha Ishtiaq, Shazia Bashir
Abstract: Objectives: To determine etiology and spectrum of trauma in children and to make recommendations for its prevention. Materials and Methods: This Hospital based Retrospective observational study was conducted in Department of Pediatric Surgery King Edward Medical University / Mayo Hospital Lahore from March 2021 to February 2022. All patients presented in Pediatric Surgical emergency King Edward Medical University/ Mayo Hospital Lahore were included in this study. Data regarding age, gender, mechanism and severity of trauma and its management was analyzed and recorded on a prescribed Performa. Results: During the study period a total of 3850 patients having trauma were presented in pediatric surgical emergency. There were 2206 (57.3%) male patients and 1644 (42.7%) females with male to female ratio of 1.3:1. Majority of children affected were 8 to 10 years age. Burn trauma was noted in 2400 (62.3%) while 1450 (37.7%) patients have poly trauma due to different etiological factors. Regarding burn trauma, majority of patients 1620 (67.5%) were having scald burn injury. Pedestrians 260 (17.9%) hitting with motor vehicle was noted to be major mechanism of trauma. Conclusion: Motor vehicle collision is most common mechanism of pediatric trauma after pediatric burn injury. There is a need for parental education and strict implementation of traffic laws to prevent trauma at pediatric age group.
摘要:目的:确定儿童创伤的病因和谱系,并提出预防建议。材料与方法:本研究于2021年3月至2022年2月在拉合尔爱德华国王医科大学/梅奥医院儿科外科进行回顾性观察性研究。所有在拉合尔爱德华国王医科大学/梅奥医院儿科外科急诊就诊的患者均纳入本研究。对年龄、性别、机制、创伤严重程度及其处理等数据进行分析并记录在规定的performance表上。结果:在研究期间,共有3850例创伤患者出现在儿科外科急诊。男性2206例(57.3%),女性1644例(42.7%),男女比例为1.3:1。大多数受影响的儿童年龄在8至10岁之间。烧伤2400例(62.3%),多伤1450例(37.7%)。烧伤方面,1620例(67.5%)患者以烫伤烧伤为主。行人260例(17.9%)被机动车撞击是主要的创伤机制。结论:机动车碰撞是儿童烧伤后最常见的创伤机制。需要父母的教育和严格执行交通法规,以防止儿童年龄组的创伤。
{"title":"Frequency and Etiology of Pediatric Trauma, Experience at Tertiary Care Hospital","authors":"M. Bashir, Aisha Ishtiaq, Shazia Bashir","doi":"10.21089/njhs.73.0121","DOIUrl":"https://doi.org/10.21089/njhs.73.0121","url":null,"abstract":"Abstract: Objectives: To determine etiology and spectrum of trauma in children and to make recommendations for its prevention. Materials and Methods: This Hospital based Retrospective observational study was conducted in Department of Pediatric Surgery King Edward Medical University / Mayo Hospital Lahore from March 2021 to February 2022. All patients presented in Pediatric Surgical emergency King Edward Medical University/ Mayo Hospital Lahore were included in this study. Data regarding age, gender, mechanism and severity of trauma and its management was analyzed and recorded on a prescribed Performa. Results: During the study period a total of 3850 patients having trauma were presented in pediatric surgical emergency. There were 2206 (57.3%) male patients and 1644 (42.7%) females with male to female ratio of 1.3:1. Majority of children affected were 8 to 10 years age. Burn trauma was noted in 2400 (62.3%) while 1450 (37.7%) patients have poly trauma due to different etiological factors. Regarding burn trauma, majority of patients 1620 (67.5%) were having scald burn injury. Pedestrians 260 (17.9%) hitting with motor vehicle was noted to be major mechanism of trauma. Conclusion: Motor vehicle collision is most common mechanism of pediatric trauma after pediatric burn injury. There is a need for parental education and strict implementation of traffic laws to prevent trauma at pediatric age group.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"99 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127271060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inherited Bone Marrow Failure Syndromes – Challenges and Updates 遗传性骨髓衰竭综合征-挑战和更新
Pub Date : 2022-09-30 DOI: 10.21089/njhs.73.0129
S. A. Jiskani, Saleem Akhtar Shaikh, R. Talpur
Abstract: Congenital or inherited bone marrow failure syndromes are hereditary syndromes of diverse nature which are characterized by inadequate production of blood cells causing cytopenias. Failure of bone marrow can be limited to one or more lineages of blood cells, along with symptoms specified to lineage, through it can affect all cell lineages leading to clinical picture like aplastic anemia. These syndromes are genetic diseases of heterogenous nature caused by germline mutations affecting basic pathways of cell including telomerase biology, biogenesis of ribosomes, structural proteins, and repair of DNA. Common inherited bone marrow failure syndromes consist of Schwachman – Diamond syndrome, Diamond – Blackfan anemia, Fanconi anemia, and Dyskeratosis Congenita. These syndromes have different prognosis and tendency to develop solid or hematological malignancies. Therefore, the adequate diagnosis of these disorders and their differentiation from other bone marrow failure syndromes and/or other etiologies of the boe marrow failure is very significant for surveillance and management of patients. Acquired causes may also lead to bone marrow failure including radiations, chemicals, drugs, immune diseases, viral infections, myelodysplastic syndromes, large granular lymphocytic leukemia, or paroxysmal nocturnal hemoglobinuria (PNH). Inherited bone marrow failure syndromes are heritable and affects family members as well, therefore need genetic counselling. In this review, differential diagnosis, various causes, and their pathogenesis are discussed for better understanding of inherited bone marrow failure syndromes.
摘要先天性或遗传性骨髓衰竭综合征是一种以血细胞产生不足引起细胞减少为特征的多种遗传性综合征。骨髓衰竭可局限于一个或多个血细胞系,并伴有特定谱系的症状,通过它可以影响所有细胞系,导致再生障碍性贫血等临床症状。这些综合征是由影响细胞基本途径的种系突变引起的异质性遗传性疾病,包括端粒酶生物学、核糖体的生物发生、结构蛋白和DNA修复。常见的遗传性骨髓衰竭综合征包括Schwachman - Diamond综合征、Diamond - Blackfan贫血、Fanconi贫血和先天性角化不良。这些综合征有不同的预后和发展为实体或血液系统恶性肿瘤的倾向。因此,充分诊断这些疾病,并将其与其他骨髓衰竭综合征和/或其他病因的骨髓衰竭区分开来,对于患者的监测和管理非常重要。获得性原因也可能导致骨髓衰竭,包括辐射、化学物质、药物、免疫疾病、病毒感染、骨髓增生异常综合征、大颗粒淋巴细胞白血病或阵发性夜间血红蛋白尿(PNH)。遗传性骨髓衰竭综合征是可遗传的,也会影响到家庭成员,因此需要遗传咨询。本文就遗传性骨髓衰竭综合征的鉴别诊断、各种病因及其发病机制进行综述,以期更好地了解遗传性骨髓衰竭综合征。
{"title":"Inherited Bone Marrow Failure Syndromes – Challenges and Updates","authors":"S. A. Jiskani, Saleem Akhtar Shaikh, R. Talpur","doi":"10.21089/njhs.73.0129","DOIUrl":"https://doi.org/10.21089/njhs.73.0129","url":null,"abstract":"Abstract: Congenital or inherited bone marrow failure syndromes are hereditary syndromes of diverse nature which are characterized by inadequate production of blood cells causing cytopenias. Failure of bone marrow can be limited to one or more lineages of blood cells, along with symptoms specified to lineage, through it can affect all cell lineages leading to clinical picture like aplastic anemia. These syndromes are genetic diseases of heterogenous nature caused by germline mutations affecting basic pathways of cell including telomerase biology, biogenesis of ribosomes, structural proteins, and repair of DNA. Common inherited bone marrow failure syndromes consist of Schwachman – Diamond syndrome, Diamond – Blackfan anemia, Fanconi anemia, and Dyskeratosis Congenita. These syndromes have different prognosis and tendency to develop solid or hematological malignancies. Therefore, the adequate diagnosis of these disorders and their differentiation from other bone marrow failure syndromes and/or other etiologies of the boe marrow failure is very significant for surveillance and management of patients. Acquired causes may also lead to bone marrow failure including radiations, chemicals, drugs, immune diseases, viral infections, myelodysplastic syndromes, large granular lymphocytic leukemia, or paroxysmal nocturnal hemoglobinuria (PNH). Inherited bone marrow failure syndromes are heritable and affects family members as well, therefore need genetic counselling. In this review, differential diagnosis, various causes, and their pathogenesis are discussed for better understanding of inherited bone marrow failure syndromes.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125605733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complete Labial Fusion in a Post Menarche Adolescent Girl 初潮后少女完全唇融合
Pub Date : 2022-09-30 DOI: 10.21089/njhs.73.0139
Anum Fatima Parekh, Ayesha Khan, S. Ali
Abstract: Labial fusion is commonly seen in pre-pubertal girls but is rarely reported in adolescent females after menarche. Its main cause is low estrogen levels. A patient can be completely asymptomatic and self-limiting or present with a wide range of symptoms which can vary from urinary tract infection, urine retention, incontinence, dyspareunia, etc. We present a case of a 12-year-old female who presented in our department with a complaint of difficulty in voiding and lower urinary tract symptoms. After a detailed examination, she was diagnosed with labial fusion for which adhesiolysis was done and patient remained asymptomatic after it.
摘要:唇融合常见于青春期前女孩,但在初潮后的青春期女性中很少报道。其主要原因是雌激素水平低。患者可以完全无症状和自限性,也可以表现出多种症状,如尿路感染、尿潴留、尿失禁、性交困难等。我们提出一个12岁的女性谁提出了在我们的部门与排尿困难和下尿路症状的投诉。经过详细的检查,她被诊断为唇融合,并进行粘连松解术,术后患者无症状。
{"title":"Complete Labial Fusion in a Post Menarche Adolescent Girl","authors":"Anum Fatima Parekh, Ayesha Khan, S. Ali","doi":"10.21089/njhs.73.0139","DOIUrl":"https://doi.org/10.21089/njhs.73.0139","url":null,"abstract":"Abstract: Labial fusion is commonly seen in pre-pubertal girls but is rarely reported in adolescent females after menarche. Its main cause is low estrogen levels. A patient can be completely asymptomatic and self-limiting or present with a wide range of symptoms which can vary from urinary tract infection, urine retention, incontinence, dyspareunia, etc. We present a case of a 12-year-old female who presented in our department with a complaint of difficulty in voiding and lower urinary tract symptoms. After a detailed examination, she was diagnosed with labial fusion for which adhesiolysis was done and patient remained asymptomatic after it.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"413 2-3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131400315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Retrospective Audit of Treatment Non-Compliance among Osteosarcoma Patients from a Developing Country 一个发展中国家骨肉瘤患者治疗不依从性的回顾性审计
Pub Date : 2022-09-30 DOI: 10.21089/njhs.73.0110
Badaruddin Sahito, Sheikh Muhammad Ebad Ali, Mustafa Saleem, N. Soomro, M. Katto, Asif Jatoi
Abstract: Background: The study aims to assess the non-compliance rate along with the factors affecting the non-compliance among osteosarcoma patients presenting in our institution. Materials and Methods: Osteosarcoma patients who were treated at our institution between January 2014 to December 2020 were included in this study. Records were searched from Departmental Cancer Registry for details regarding treatment plans and follow-ups. The data of outcomes were compared with the standard guidelines. Patients who did not attend follow-ups, surgery or chemotherapy were termed as non-compliant. The patients or their next of kins were inquired about the factors behind non-compliance. Results: The study sample included 46 participants where 34 (74.9%) and 12 (26.1%) were male and females, respectively with a mean age of 19.7± 9.7 years. 11 (23.91%) participants were compliant with the prescribed treatment plans that included surgery, neoadjuvant, and adjuvant treatments whereas 35 (76.1%) of the participants were non-compliant either with surgery or chemotherapy. Amongst all included participants, the neoadjuvant chemotherapy plan was followed by 18 (39.13%) and adjuvant chemotherapy was followed by 10 (21.74%) candidates. Surgery was performed in 22 (44.9%). The patients who did not received chemotherapy was attributed to affordability (P=0.008) and patients’ or next to kins’ choices (P=0.02) while age (P=0.039), patients’ consent not given (78.3%; P=0.05), and stage II (52.2%; P=0.048) were predictors of surgical non-compliance. Conclusion: We conclude that the care deferred significantly from the guidelines regarding surgery and chemotherapy. Age, affordability, late stage, and personal choices are the significant predictors for non-compliance for chemotherapy and surgery.
摘要:背景:本研究旨在了解本院骨肉瘤患者的不遵规率及其影响不遵规的因素。材料与方法:2014年1月至2020年12月在我院治疗的骨肉瘤患者纳入本研究。我们从部门癌症登记处检索了有关治疗计划和随访的详细记录。结果数据与标准指南进行比较。未参加随访、手术或化疗的患者被称为不遵医嘱。询问患者或其近亲属不遵医嘱的原因。结果:共纳入46例患者,其中男性34例(74.9%),女性12例(26.1%),平均年龄19.7±9.7岁。11名(23.91%)参与者遵守规定的治疗计划,包括手术、新辅助和辅助治疗,而35名(76.1%)参与者不遵守手术或化疗。其中新辅助化疗18例(39.13%),辅助化疗10例(21.74%)。手术22例(44.9%)。未接受化疗的患者分别为负担能力(P=0.008)、患者或亲属选择(P=0.02)、年龄(P=0.039)、未给予患者同意(78.3%;P=0.05), II期占52.2%;P=0.048)是手术不顺应性的预测因素。结论:我们得出的结论是,护理明显推迟了指导方针的手术和化疗。年龄、负担能力、晚期和个人选择是化疗和手术不依从性的重要预测因素。
{"title":"A Retrospective Audit of Treatment Non-Compliance among Osteosarcoma Patients from a Developing Country","authors":"Badaruddin Sahito, Sheikh Muhammad Ebad Ali, Mustafa Saleem, N. Soomro, M. Katto, Asif Jatoi","doi":"10.21089/njhs.73.0110","DOIUrl":"https://doi.org/10.21089/njhs.73.0110","url":null,"abstract":"Abstract: Background: The study aims to assess the non-compliance rate along with the factors affecting the non-compliance among osteosarcoma patients presenting in our institution. Materials and Methods: Osteosarcoma patients who were treated at our institution between January 2014 to December 2020 were included in this study. Records were searched from Departmental Cancer Registry for details regarding treatment plans and follow-ups. The data of outcomes were compared with the standard guidelines. Patients who did not attend follow-ups, surgery or chemotherapy were termed as non-compliant. The patients or their next of kins were inquired about the factors behind non-compliance. Results: The study sample included 46 participants where 34 (74.9%) and 12 (26.1%) were male and females, respectively with a mean age of 19.7± 9.7 years. 11 (23.91%) participants were compliant with the prescribed treatment plans that included surgery, neoadjuvant, and adjuvant treatments whereas 35 (76.1%) of the participants were non-compliant either with surgery or chemotherapy. Amongst all included participants, the neoadjuvant chemotherapy plan was followed by 18 (39.13%) and adjuvant chemotherapy was followed by 10 (21.74%) candidates. Surgery was performed in 22 (44.9%). The patients who did not received chemotherapy was attributed to affordability (P=0.008) and patients’ or next to kins’ choices (P=0.02) while age (P=0.039), patients’ consent not given (78.3%; P=0.05), and stage II (52.2%; P=0.048) were predictors of surgical non-compliance. Conclusion: We conclude that the care deferred significantly from the guidelines regarding surgery and chemotherapy. Age, affordability, late stage, and personal choices are the significant predictors for non-compliance for chemotherapy and surgery.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115147194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Overview of Diabetes Mellitus in Egypt as a Major Public Health Problem 概述糖尿病在埃及作为一个主要的公共卫生问题
Pub Date : 2022-01-25 DOI: 10.21089/njhs.62.0080
M. Riad, Shorouk M Elshafei
Abstract: Introduction: The prevalence of diabetes mellitus is rising rapidly in Egypt with major health and socioeconomic consequences. The shortage of endocrinologists is another important issue in Egypt that must be taken into consideration. Objective: To review and discuss the epidemiology, risk factors, and different ways of diabetes care in Egypt. In addition, the aim is also to analyze the problem of the shortage of endocrinologists and how it can be solved. Methods: Searching and reviewing medical literature using PubMed, Google scholar, and some other gray literature from the World Health Organization (WHO), International Diabetes Federation (IDF), and Centers for Disease Control and Prevention (CDC). Results: Egypt is ranked ninth in the prevalence of diabetes worldwide according to IDF with a prevalence of 15.2% in the adult population in early 2020. The prevalence is expected to continue rising to more serious levels. This high prevalence is attributed to common risk factors in Egypt such as obesity, physical inactivity, chronic hepatitis C infection, pesticides, smoking, and bad eating habits. Moreover, we are in an increased demand for more endocrinologists in the Egyptian health care system. Conclusion: Understanding and avoiding the risk factors of diabetes is a crucial step towards reducing its prevalence and minimizing its healthcare and socioeconomic burdens in Egypt. Effective strategies should be applied for proper diabetes management and improving the quality of life in diabetic patients. Increasing the number of endocrinologists is also a key element for better diabetes care. Keywords: Diabetes in Egypt, Diabetes epidemiology, Hepatitis C virus, Obesity, Smoking, Pesticides.
摘要:导读:糖尿病的患病率在埃及迅速上升,造成了严重的健康和社会经济后果。缺乏内分泌学家是埃及另一个必须考虑的重要问题。目的:回顾和探讨埃及糖尿病的流行病学、危险因素及不同的糖尿病护理方式。此外,还旨在分析内分泌专家短缺的问题及如何解决。方法:使用PubMed、Google scholar以及来自世界卫生组织(WHO)、国际糖尿病联合会(IDF)和美国疾病控制与预防中心(CDC)的灰色文献进行检索和综述。结果:根据IDF的数据,埃及在全球糖尿病患病率中排名第九,2020年初成人患病率为15.2%。预计流行率将继续上升到更严重的水平。这种高患病率归因于埃及常见的危险因素,如肥胖、缺乏身体活动、慢性丙型肝炎感染、农药、吸烟和不良饮食习惯。此外,我们对埃及卫生保健系统中更多内分泌学家的需求也在增加。结论:了解和避免糖尿病的危险因素是在埃及减少其患病率和减少其医疗保健和社会经济负担的关键一步。应采取有效的策略,妥善管理糖尿病,提高糖尿病患者的生活质量。增加内分泌学家的数量也是改善糖尿病护理的关键因素。关键词:埃及糖尿病,糖尿病流行病学,丙型肝炎病毒,肥胖,吸烟,农药
{"title":"An Overview of Diabetes Mellitus in Egypt as a Major Public Health Problem","authors":"M. Riad, Shorouk M Elshafei","doi":"10.21089/njhs.62.0080","DOIUrl":"https://doi.org/10.21089/njhs.62.0080","url":null,"abstract":"Abstract: Introduction: The prevalence of diabetes mellitus is rising rapidly in Egypt with major health and socioeconomic consequences. The shortage of endocrinologists is another important issue in Egypt that must be taken into consideration. Objective: To review and discuss the epidemiology, risk factors, and different ways of diabetes care in Egypt. In addition, the aim is also to analyze the problem of the shortage of endocrinologists and how it can be solved. Methods: Searching and reviewing medical literature using PubMed, Google scholar, and some other gray literature from the World Health Organization (WHO), International Diabetes Federation (IDF), and Centers for Disease Control and Prevention (CDC). Results: Egypt is ranked ninth in the prevalence of diabetes worldwide according to IDF with a prevalence of 15.2% in the adult population in early 2020. The prevalence is expected to continue rising to more serious levels. This high prevalence is attributed to common risk factors in Egypt such as obesity, physical inactivity, chronic hepatitis C infection, pesticides, smoking, and bad eating habits. Moreover, we are in an increased demand for more endocrinologists in the Egyptian health care system. Conclusion: Understanding and avoiding the risk factors of diabetes is a crucial step towards reducing its prevalence and minimizing its healthcare and socioeconomic burdens in Egypt. Effective strategies should be applied for proper diabetes management and improving the quality of life in diabetic patients. Increasing the number of endocrinologists is also a key element for better diabetes care. Keywords: Diabetes in Egypt, Diabetes epidemiology, Hepatitis C virus, Obesity, Smoking, Pesticides.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129855830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Current Situation in the Struggle against Novel Coronavirus Infection (Covid-19) 抗击新型冠状病毒感染的现状
Pub Date : 2022-01-25 DOI: 10.21089/njhs.62.0044
G. Aktas
The lives of billions in the world have become to change by the end of 2019, almost two years ago, after novel coronavirus (Covid-19) infection emerged in Wuhan, China. Covid-19 caused about 33 millions of infection and 1000040 deaths worldwide within 10 months of the pandemic [1]. By December 18th of 2021, number of the infected subjects and deaths rose up to 274 million and 5364119, respectively [2]. Despite its devastating effect on human life, not even a single drug has shown significant enough efficacy against Covid-19 to change the course of the pandemic. However, some new agents and repurposed drugs were able to show efficacy to some extent. In the past 2 years, we have noticed that many Covid-19 cases have actually recovered without any treatment other than general measures. Indeed, most young and middle-aged people survive the disease mildly, yet the disease can be severe in people with advanced age and who have significant additional comorbidities. That’s why, one of the most important things to do while waiting for the pandemic to end is to take and maintain measures to prevent the spread of Covid-19 in societies. Nevertheless, as the outbreak progressed, we began to consider Covid-19-related deaths as ordinary. Unfortunately, we also loosen the tight measures to control the disease.
大约两年前,在中国武汉出现新型冠状病毒(Covid-19)感染后,到2019年底,世界上数十亿人的生活发生了变化。在大流行后的10个月内,Covid-19在全球造成约3300万人感染和1000040人死亡[1]。截至2021年12月18日,感染人数和死亡人数分别上升至2.74亿人和5364119人[2]。尽管新冠肺炎对人类生命造成了毁灭性的影响,但甚至没有一种药物显示出足够显著的疗效来改变大流行的进程。然而,一些新的药物和重新利用的药物能够显示出一定程度的疗效。我们注意到,近两年来,许多新冠肺炎病例在不采取任何治疗措施的情况下,实际上已经康复。事实上,大多数年轻人和中年人在这种疾病中存活得很轻,但对于老年和有明显其他合并症的人来说,这种疾病可能很严重。因此,在等待大流行结束的同时,最重要的事情之一是采取并维持措施,防止Covid-19在社会中传播。然而,随着疫情的发展,我们开始认为与covid -19相关的死亡是正常的。不幸的是,我们也放松了严格的控制疾病的措施。
{"title":"Current Situation in the Struggle against Novel Coronavirus Infection (Covid-19)","authors":"G. Aktas","doi":"10.21089/njhs.62.0044","DOIUrl":"https://doi.org/10.21089/njhs.62.0044","url":null,"abstract":"The lives of billions in the world have become to change by the end of 2019, almost two years ago, after novel coronavirus (Covid-19) infection emerged in Wuhan, China. Covid-19 caused about 33 millions of infection and 1000040 deaths worldwide within 10 months of the pandemic [1]. By December 18th of 2021, number of the infected subjects and deaths rose up to 274 million and 5364119, respectively [2]. Despite its devastating effect on human life, not even a single drug has shown significant enough efficacy against Covid-19 to change the course of the pandemic. However, some new agents and repurposed drugs were able to show efficacy to some extent. In the past 2 years, we have noticed that many Covid-19 cases have actually recovered without any treatment other than general measures. Indeed, most young and middle-aged people survive the disease mildly, yet the disease can be severe in people with advanced age and who have significant additional comorbidities. That’s why, one of the most important things to do while waiting for the pandemic to end is to take and maintain measures to prevent the spread of Covid-19 in societies. Nevertheless, as the outbreak progressed, we began to consider Covid-19-related deaths as ordinary. Unfortunately, we also loosen the tight measures to control the disease.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133914072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Red Cell Distribution Width and Mortality in Hemodialysis Patients: A Single Center Experience in COVID-19 Era 血透患者红细胞分布宽度与死亡率:COVID-19时代的单中心经验
Pub Date : 2022-01-25 DOI: 10.21089/njhs.62.0061
M. Topal, I. Guney
Abstract: Introduction: Red Cell Distribution width (RDW) is found to be related with mortality in hemodialysis patients. In December 2019, a new corona virus spread was detected in China, which turned into a pandemia with significant mortality. Both RDW and chronic kidney disease were found to be related with mortality in COVID-19 patients. This study investigated if the association of RDW and mortality in hemodialysis patients still existed in the COVID-19 era. Materials and Methods: This single center study included 117 hemodialysis patients. They were followed for 20 months (between December 2019 and July 2021) or until death. The relation of RDW with all-cause mortality and COVID-19 related deaths were studied. Results: 21 (17.9%) out of 117 patients died during the follow-up. RDW was found to be an independent risk factor for all-cause mortality (HR:1.35, p=0.009). In post-hoc analyzes, RDW was significantly higher in non-COVID-19 related and cardiovascular deaths. Conclusion: RDW was found to be an independent and powerful risk factor of all-cause and cardiovascular mortality even in the mortal COVID-19 era. Keywords: Red cell distribution width, Hemodialysis, Mortality, COVID-19, Chronic kidney disease, Rheumatoid arthtritis.
摘要:导读:血透患者红细胞分布宽度(RDW)与死亡率相关。2019年12月,中国发现了一种新的冠状病毒传播,并演变成一场死亡率很高的大流行。发现RDW和慢性肾脏疾病与COVID-19患者的死亡率相关。本研究探讨在COVID-19时代,血透患者的RDW与死亡率是否仍然存在关联。材料与方法:本研究纳入117例血液透析患者。他们被跟踪了20个月(2019年12月至2021年7月)或直到死亡。研究RDW与全因死亡率和COVID-19相关死亡的关系。结果:117例患者中有21例(17.9%)在随访期间死亡。发现RDW是全因死亡率的独立危险因素(HR:1.35, p=0.009)。在事后分析中,RDW在非covid -19相关死亡和心血管死亡中显著更高。结论:即使在致命的COVID-19时代,RDW仍是全因死亡率和心血管死亡率的独立且强大的危险因素。关键词:红细胞分布宽度,血液透析,死亡率,COVID-19,慢性肾病,类风湿性关节炎
{"title":"Red Cell Distribution Width and Mortality in Hemodialysis Patients: A Single Center Experience in COVID-19 Era","authors":"M. Topal, I. Guney","doi":"10.21089/njhs.62.0061","DOIUrl":"https://doi.org/10.21089/njhs.62.0061","url":null,"abstract":"Abstract: Introduction: Red Cell Distribution width (RDW) is found to be related with mortality in hemodialysis patients. In December 2019, a new corona virus spread was detected in China, which turned into a pandemia with significant mortality. Both RDW and chronic kidney disease were found to be related with mortality in COVID-19 patients. This study investigated if the association of RDW and mortality in hemodialysis patients still existed in the COVID-19 era. Materials and Methods: This single center study included 117 hemodialysis patients. They were followed for 20 months (between December 2019 and July 2021) or until death. The relation of RDW with all-cause mortality and COVID-19 related deaths were studied. Results: 21 (17.9%) out of 117 patients died during the follow-up. RDW was found to be an independent risk factor for all-cause mortality (HR:1.35, p=0.009). In post-hoc analyzes, RDW was significantly higher in non-COVID-19 related and cardiovascular deaths. Conclusion: RDW was found to be an independent and powerful risk factor of all-cause and cardiovascular mortality even in the mortal COVID-19 era. Keywords: Red cell distribution width, Hemodialysis, Mortality, COVID-19, Chronic kidney disease, Rheumatoid arthtritis.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"63 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133513914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative Hypotension: Immediate and Short Term Impact on Mortality. Findings from a High Dependency Cardiac and Vascular Surgical Center in Nigeria 术中低血压:对死亡率的直接和短期影响。来自尼日利亚一个高依赖性心脏和血管外科中心的发现
Pub Date : 2022-01-25 DOI: 10.21089/njhs.62.0067
P. Uduagbamen, M. Sanusi, O. Udom, S. Ahmed, O. Ehioghae, Olutomiwa Omokore
Abstract: Introduction: Intraoperative hypotension in cardiac surgery could be complicated by acute kidney injury (AKI), cardiac arrest and death due to poor organ perfusion. We studied intraoperative hypotension (IOH) and its immediate and short term relationship with post-operative mortality. Materials & Methods: A retrospective study of participants, 16-86 years old who underwent cardiac and vascular surgery at Tristate Heart and Vascular Center, Ilishan-Remo, Nigeria, a high dependency cardiac and vascular surgical center between January 2015 and March 2021. Study participants were grouped into three cohorts and primary outcome was all-cause post-operative death. Results: The records of four hundred and fifteen (258 males and 157 females) cohorts were studied, with mean age of 56.6 ± 5.4 years, 14.69% of the participants were 65 years or older. The surgeries were coronary artery bypass graft (CABG) alone (26.03%), CABG with valve surgery (38.31%) and, valves surgery alone (35.66%). The mean arterial pressure (MAP) pre-induction, and intra-operative and immediate post-op were 71.37 ± 14 09 mmHg, 68.6 ± 11.24 mmHg and 72.24 ± 33 mmHg respectively. The incidence of IOH was 86.30%, prevalence of background kidney dysfunction was 29.40% and incidence of AKI was 25.54%. Eleven (2.65%) participants died, all (100%) had IOH, 1 (9.09%) was intradialytic. The predictors of mortality were aging (aOR-4.23, 1.65-5.85), IOH (aOR-1.55, CI-0.34-1.96), background kidney disease (aOR-3.96, CI-1.43-4.78), comorbidity (aOR-2.77, CI-0.87-3.17), emergency surgery (aOR-4.62, CI-1.35-5.12), pre-induction MAP (aOR-4.22, CI-3.15-6.49) and, combined CABG and valve surgery (aOR-2.17, CI-1.69-4.57)). Conclusion: Intraoperative hypotension commonly results from cardiac and vascular surgeries and could be complicated by AKI, cardiac arrest and death. The risk of these complications is increased by background kidney disease, comorbidities and episodes of IOH. Keywords: Intraoperative hypotension, Coronary artery bypass graft, Acute kidney injury, Cardiac arrest, Mortality, Mean arterial pressure.
摘要:导论:心脏手术术中低血压可并发急性肾损伤(AKI)、心脏骤停和器官灌注不良导致的死亡。我们研究了术中低血压(IOH)及其与术后死亡率的直接和短期关系。材料与方法:回顾性研究参与者,年龄16-86岁,于2015年1月至2021年3月期间在尼日利亚Ilishan-Remo的Tristate心脏和血管中心(一个高度依赖的心脏和血管手术中心)接受心脏和血管手术。研究参与者被分为三个队列,主要结局为全因术后死亡。结果:共纳入415例(男258例,女157例)队列,平均年龄56.6±5.4岁,年龄≥65岁者占14.69%。分别为单纯冠状动脉搭桥(CABG)(26.03%)、冠状动脉搭桥联合瓣膜手术(38.31%)和单纯瓣膜手术(35.66%)。诱导前、术中、术后即刻平均动脉压(MAP)分别为71.37±14 09 mmHg、68.6±11.24 mmHg和72.24±33 mmHg。IOH发生率为86.30%,背景肾功能不全发生率为29.40%,AKI发生率为25.54%。11例(2.65%)死亡,全部(100%)有IOH, 1例(9.09%)有透析。死亡预测因子为年龄(aOR-4.23, 1.65-5.85)、IOH (aOR-1.55, CI-0.34-1.96)、背景肾病(aOR-3.96, CI-1.43-4.78)、合病(aOR-2.77, CI-0.87-3.17)、急诊手术(aOR-4.62, CI-1.35-5.12)、诱导前MAP (aOR-4.22, CI-3.15-6.49)、CABG联合瓣膜手术(aOR-2.17, CI-1.69-4.57)。结论:术中低血压通常由心脏和血管手术引起,可并发AKI、心脏骤停和死亡。这些并发症的风险增加了背景肾脏疾病,合并症和IOH发作。关键词:术中低血压,冠状动脉旁路移植术,急性肾损伤,心脏骤停,死亡率,平均动脉压。
{"title":"Intraoperative Hypotension: Immediate and Short Term Impact on Mortality. Findings from a High Dependency Cardiac and Vascular Surgical Center in Nigeria","authors":"P. Uduagbamen, M. Sanusi, O. Udom, S. Ahmed, O. Ehioghae, Olutomiwa Omokore","doi":"10.21089/njhs.62.0067","DOIUrl":"https://doi.org/10.21089/njhs.62.0067","url":null,"abstract":"Abstract: Introduction: Intraoperative hypotension in cardiac surgery could be complicated by acute kidney injury (AKI), cardiac arrest and death due to poor organ perfusion. We studied intraoperative hypotension (IOH) and its immediate and short term relationship with post-operative mortality. Materials & Methods: A retrospective study of participants, 16-86 years old who underwent cardiac and vascular surgery at Tristate Heart and Vascular Center, Ilishan-Remo, Nigeria, a high dependency cardiac and vascular surgical center between January 2015 and March 2021. Study participants were grouped into three cohorts and primary outcome was all-cause post-operative death. Results: The records of four hundred and fifteen (258 males and 157 females) cohorts were studied, with mean age of 56.6 ± 5.4 years, 14.69% of the participants were 65 years or older. The surgeries were coronary artery bypass graft (CABG) alone (26.03%), CABG with valve surgery (38.31%) and, valves surgery alone (35.66%). The mean arterial pressure (MAP) pre-induction, and intra-operative and immediate post-op were 71.37 ± 14 09 mmHg, 68.6 ± 11.24 mmHg and 72.24 ± 33 mmHg respectively. The incidence of IOH was 86.30%, prevalence of background kidney dysfunction was 29.40% and incidence of AKI was 25.54%. Eleven (2.65%) participants died, all (100%) had IOH, 1 (9.09%) was intradialytic. The predictors of mortality were aging (aOR-4.23, 1.65-5.85), IOH (aOR-1.55, CI-0.34-1.96), background kidney disease (aOR-3.96, CI-1.43-4.78), comorbidity (aOR-2.77, CI-0.87-3.17), emergency surgery (aOR-4.62, CI-1.35-5.12), pre-induction MAP (aOR-4.22, CI-3.15-6.49) and, combined CABG and valve surgery (aOR-2.17, CI-1.69-4.57)). Conclusion: Intraoperative hypotension commonly results from cardiac and vascular surgeries and could be complicated by AKI, cardiac arrest and death. The risk of these complications is increased by background kidney disease, comorbidities and episodes of IOH. Keywords: Intraoperative hypotension, Coronary artery bypass graft, Acute kidney injury, Cardiac arrest, Mortality, Mean arterial pressure.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"78 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132053680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acid Base Imbalance in Dialysis: Risk Factors and Impact on Intradialysis Blood Pressure Changes. Findings from a Single Center Prospective Study in Nigeria 透析中酸碱失衡:危险因素及对透析内血压变化的影响。尼日利亚单中心前瞻性研究结果
Pub Date : 2022-01-25 DOI: 10.21089/njhs.62.0053
P. Uduagbamen
Abstract: Introduction: Despite improvements in hemodialysis delivery, acid base imbalance is still common in the dialysis population and it is associated with intradialysis blood pressure changes, dialysis termination, inadequacy and poor treatment outcome. We studied acid base imbalance in maintenance hemodialysis, its determinants and relationship with intradialysis blood pressure changes. Materials & Methods: A prospective study carried out at Babcock University Teaching Hospital, Ilishan-Remo between May 2019 and April 2021 that involved 298 participants who had 1642 hemodialysis sessions. Results: The mean age was 51.44 + 7.31 years, with the females been older than males, P=0.04. The mean predialysis and post dialysis serum bicarbonate were 18.41 ± 3.63 mmol/l and 20.61 ± 6.26 mmol/l (P<0.001). The prevalence of pre and post dialysis metabolic acidosis were 79.0% and 38.3% (P<0.001) and of intradialysis hypotension and hypertension were 19.1% and 25.0% (P=0.02). The risk of intradialysis hypotension was negatively correlated with predialysis bicarbonate while intradialysis hypertension was positively correlated with predialysis bicarbonate. The mean dialysis dose was higher in males (P=0.03). Metabolic acidosis was commoner in elderly and females, and was associated with intradialysis hypotension, dialysis termination and inadequacy. Aging and infrequent dialysis, predicted metabolic acidosis. Conclusion: Metabolic acidosis is common in maintenance hemodialysis, particularly in females, aged and infrequent dialysis, and leads to intradialysis hypotension, dialysis termination, inadequacy and poor treatment outcome. Keywords: Metabolic acidosis, Maintenance hemodialysis, Dialysis dose, Intradialysis hypotension, Intradialysis hypertension, Predialysis bicarbonate, Poor treatment outcome.
摘要:导论:尽管血液透析输送有所改善,但酸碱失衡在透析人群中仍然很常见,它与透析内血压变化、透析终止、不充分和治疗结果差有关。我们研究了维持性血液透析中酸碱失衡的影响因素及其与透析中血压变化的关系。材料与方法:一项前瞻性研究于2019年5月至2021年4月在伊利山-雷莫的巴布科克大学教学医院进行,涉及298名参与者,他们进行了1642次血液透析。结果:患者平均年龄51.44 + 7.31岁,女性年龄大于男性,P=0.04。透析前和透析后血清碳酸氢盐均值分别为18.41±3.63 mmol/l和20.61±6.26 mmol/l (P<0.001)。透析前、透析后代谢性酸中毒发生率分别为79.0%、38.3% (P<0.001),透析中低血压、高血压发生率分别为19.1%、25.0% (P=0.02)。透析前碳酸氢盐与透析内低血压呈负相关,透析前碳酸氢盐与透析内高血压呈正相关。男性的平均透析剂量较高(P=0.03)。代谢性酸中毒常见于老年人和女性,并与透析时低血压、透析终止和透析不足相关。衰老和不常透析,预示代谢性酸中毒。结论:代谢性酸中毒在维持性血液透析中很常见,尤其是在女性、老年和不经常透析中,并导致分析中低血压、透析终止、透析不充分和治疗效果差。关键词:代谢性酸中毒,维持性血液透析,透析剂量,透析内低血压,透析内高血压,透析前碳酸氢盐,治疗效果差
{"title":"Acid Base Imbalance in Dialysis: Risk Factors and Impact on Intradialysis Blood Pressure Changes. Findings from a Single Center Prospective Study in Nigeria","authors":"P. Uduagbamen","doi":"10.21089/njhs.62.0053","DOIUrl":"https://doi.org/10.21089/njhs.62.0053","url":null,"abstract":"Abstract: Introduction: Despite improvements in hemodialysis delivery, acid base imbalance is still common in the dialysis population and it is associated with intradialysis blood pressure changes, dialysis termination, inadequacy and poor treatment outcome. We studied acid base imbalance in maintenance hemodialysis, its determinants and relationship with intradialysis blood pressure changes. Materials & Methods: A prospective study carried out at Babcock University Teaching Hospital, Ilishan-Remo between May 2019 and April 2021 that involved 298 participants who had 1642 hemodialysis sessions. Results: The mean age was 51.44 + 7.31 years, with the females been older than males, P=0.04. The mean predialysis and post dialysis serum bicarbonate were 18.41 ± 3.63 mmol/l and 20.61 ± 6.26 mmol/l (P<0.001). The prevalence of pre and post dialysis metabolic acidosis were 79.0% and 38.3% (P<0.001) and of intradialysis hypotension and hypertension were 19.1% and 25.0% (P=0.02). The risk of intradialysis hypotension was negatively correlated with predialysis bicarbonate while intradialysis hypertension was positively correlated with predialysis bicarbonate. The mean dialysis dose was higher in males (P=0.03). Metabolic acidosis was commoner in elderly and females, and was associated with intradialysis hypotension, dialysis termination and inadequacy. Aging and infrequent dialysis, predicted metabolic acidosis. Conclusion: Metabolic acidosis is common in maintenance hemodialysis, particularly in females, aged and infrequent dialysis, and leads to intradialysis hypotension, dialysis termination, inadequacy and poor treatment outcome. Keywords: Metabolic acidosis, Maintenance hemodialysis, Dialysis dose, Intradialysis hypotension, Intradialysis hypertension, Predialysis bicarbonate, Poor treatment outcome.","PeriodicalId":441304,"journal":{"name":"National Journal of Health Sciences","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132937668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
National Journal of Health Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1